SUD Life Global Opportunity Maximizer Fund, fund provides diversified exposure across international markets and asset classes. While its core allocation is centred on equities, fund managers will have the flexibility to invest in commodities, enabling participation in both cyclical and structural growth trends. By tapping into developed and emerging economies, the fund aims to capture opportunities across themes and sectors to give back better dollar-denominated returns.

“This product is tailored for individuals with higher-risk appetite who are looking for dynamic diversification across geographies, asset classes, and sectors,” said Ram Kamal Samanta, Chief Investment Officer, SUD Life.

SUD Life Global Opportunity Maximizer Fund, which is available under SUD Life International Wealth Creator Plan, offers NRIs, PIOs, OCIs, and Resident Indians (RIs) globally diversified wealth-building opportunities, besides a comprehensive protection solution.

 This plan enables policyholders to invest in various specialised international funds – SUD Life GIFT Global Opportunity Maximizer Fund, SUD Life GIFT India Focused Fund, SUD Life GIFT US Equity Fund, SUD Life GIFT Global Equity Fund, SUD Life GIFT US Treasuries Fund, SUD Life GIFT EM Treasury Fund, and the SUD Life GIFT Commodities Fund – each designed to match evolving financial goals and risk profiles.

SUD Life GIFT Global Opportunity Maximizer Fund is open for subscription till December 22, 2025.

The post Discover the Benefits of SUD Life’s GIFT City – GIFT Global Opportunity Maximizer Fund appeared first on NRI News.

There was one observation during that inspection, and the GLS had submitted its response within the stipulated time.

With this approval, the GLS facility is now deemed approved by the U.S. FDA, marking a major milestone for Granules India as it expands its finished dosage manufacturing capabilities. This is the first FDA approval for the GLS site.

The company plans to launch the approved product in the U.S. market soon. The same product is already approved and manufactured at Granules’ Gagillapur facility. The new approval will help strengthen market share and support business continuity through multi-site manufacturing.

“We plan on launching the product into the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited. “We also have other products filed from this site and expect the U.S. FDA to approve them following necessary audits if required. This marks the first approval from our second Hyderabad facility with finished dosage capabilities.”

The post Granules Life Sciences Achieves Milestone with First U.S. FDA Approval for Hyderabad Facility appeared first on NRI News.

The mission of this center is to develop and deploy future-ready cloud solutions for Pharmaceutical, Medtech, Biotech, Healthcare, Animal Health, and CDMOs to help them address the specific compliance & life science industry-related nuances, enabling regulatory compliance, real-time insights, seamless data integration, and enhanced collaboration across the global value chain. This will allow Life Sciences companies to accelerate breakthroughs and improve patient outcomes. These cloud solutions are becoming specifically relevant in the new therapies, Biotech and Advanced Therapeutic Medicinal Products, the new Internet of Medical Things (IoMT), as well as in the next generation of CDMOs.

The latest state-of-the-art facility at Baner was inaugurated by Mr. Michael Schmidt, Founder and Member of the Executive Board of Tenthpin, in the presence of Ms. Stephanie Marx, Partner and Key Account Delivery Lead, and Sachin Bhure, Partner and Managing Director, Tenthpin India.

Speaking on the occasion, Michael Schmidt said, “Opening of our new office in Pune marks an important milestone in Tenthpin’s global growth journey. Pune plays a pivotal role in delivering innovative, high-quality solutions for our Life Sciences clients around the world. With deep expertise in SAP Batch Release Hub (BRH), SAP Intelligent Clinical Supply Management (ICSM), and SAP Cell and Gene Treatment Orchestration (CGTO), and our own AI-powered, GxP-ready Tenthpin software solutions, this center will strengthen our ability to accelerate digital transformation in the Life Sciences industry.”. He also stated, “Our team in India embodies our commitment to excellence, innovation, and partnership — ensuring that Tenthpin continues to set the global benchmark for SAP S/4HANA transformations and Life Sciences cloud solutions.”

“The expansion of our presence in India underscores Tenthpin’s strong belief in the power of Indian talent and innovation. India has proven to be a cornerstone of our global delivery model — combining exceptional expertise, technical excellence, and a deep commitment to quality,” said Stephanie Marx, Partner at Tenthpin. “With this step, we are further strengthening our capability to deliver high-value services and next-generation digital solutions to our life sciences clients worldwide.“

Tenthpin Solutions, a group company of Tenthpin, is also expanding its footprint in India. The new Pune center will serve as a global hub for innovation — further enhancing next-generation cloud-based products and accelerators that help Life Sciences companies simplify complexity, ensure regulatory compliance, and scale efficiently in a rapidly evolving digital ecosystem. This center will also collaborate with local research institutions, universities, and industry partners to drive advancements in Life Sciences in India.

“We also aim to help Indian Life Sciences companies to become global leaders in innovation with the help of local talent,” said Sachin Bhure, Partner and Managing Director India for Tenthpin. “Pune possesses world world-class talent pool, and the augmentation of this talent and practitioners will help in the speed to market and innovation to a great extent. We plan to expand our India footprint to double of current team in the next year, across all locations.”.

Jürgen Bauer, Founder and Chairman of the Executive Board of Tenthpin, says, “Establishing our new office in Pune is more than an expansion — it’s an investment in the future of Life Sciences innovation. India’s exceptional talent and deep technology expertise align perfectly with Tenthpin’s mission to redefine how global Life Sciences organizations run their businesses. Together with our teams in Bangalore and Hyderabad, our Pune team will be at the heart of co-creating intelligent, compliant, and transformative solutions for our clients worldwide. We are excited to build a center that not only delivers excellence but also fosters collaboration, creativity, and long-term value for our clients and partners.”

The post Tenthpin Expands Its Presence in India with New Life Sciences Cloud Solutions Center in Pune appeared first on NRI News.

Establishing a clear focus on protection, SBI Life’s protection new business premium stood at ₹2,211 crores for the period ended September 30, 2025, marking a growth of 29%. Protection Individual new business premium stands at ₹371 crores for the period ended September 30, 2025. Individual New Business Premium stands at ₹12,175 crores with 6% growth over the corresponding period ended on 30^th September, 2024.

SBI Life’s profit after tax stands at ₹1,089 crores for the period ended September 30, 2025, with a growth of 4% over the corresponding period ended on September 30, 2024.

The company’s solvency ratio continues to remain robust at 1.94 as of September 30, 2025, as against the regulatory requirement of 1.50.

SBI Life’s AUM also continued to grow at 10% to ₹4,81,465 crores as on September 30, 202,5, from ₹4,38,954 crores as on September 30, 2024, with the debt-equity mix of 60:40. 95% of the debt investments are in AAA and Sovereign instruments.

The company has a diversified distribution network of 343,543 trained insurance professionals and a wide presence with 1,154 offices across the country, comprising of strong bancassurance channel, agency channel, and others, comprising corporate agents, brokers, Point of sale persons (POS), insurance marketing firms, web aggregators, and direct business.

Performance for the period ended September 30, 2025

• Private Market leadership in Individual New Business Premium & Individual Rated Premium with market share of 25.4% & 22.6% respectively.
• Annualized Premium Equivalent (APE) stands at ₹9,917 crores with growth of 10%.
• Total New Business sum assured stands at ₹7,11,739 crores with 99% growth.
• Improvement in 13M persistency by 70 bps
• Value of New Business (VoNB) stands at ₹2,753 crores with a growth of 14%.
• VoNB Margin stands at 27.8%.
• Indian Embedded value (IEV) stands at ₹75,997 crores with a growth of 15%.
• Profit After Tax (PAT) stands at ₹1,089 crores with 4% growth.
• Robust Solvency ratio of 1.94.
• Assets under Management stand at ₹4,81,465 crores with 10% growth.
• Operating return on embedded value stands at 17.6%.

Disclaimer:

Except for the historical information contained herein, statements in this release that contain words or phrases such as ‘will’, ‘expected to’, etc., and similar expressions or variations of such expressions may constitute ‘forward-looking statements’. These forward-looking statements involve several risks, uncertainties, and other factors that could cause actual results, opportunities, and growth potential to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include, but are not limited to, the actual growth in demand for insurance and other financial products and services in the countries that we operate or where a material number of our customers reside, our ability to successfully implement our strategy, including our use of the Internet and other technology our exploration of merger and acquisition opportunities, our ability to integrate mergers or acquisitions into our operations and manage the risks associated with such acquisitions to achieve our strategic and financial objectives, our growth and expansion in domestic and overseas markets, technological changes, our ability to market new products, the outcome of any legal, tax or regulatory proceedings in India and in other jurisdictions we are or become a party to, the future impact of new accounting standards, our ability to implement our dividend policy, the impact of changes in insurance regulations and other regulatory changes in India and other jurisdictions on us. SBI Life Insurance Company Limited undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date thereof.

This release does not constitute an offer of securities.

The post SBI Life Insurance Achieves New Business Premium of ₹18,349 Crores by September 30, 2025 appeared first on NRI News.

• West Zone records a Protection Quotient higher than the national urban average
• Term insurance awareness and ownership rise significantly in the zone
• Mumbai leads among metros in Protection Quotient; Shares top position in Knowledge Index with Bengaluru
• 1 in 3 respondents cite financial constraints as a key barrier to term plan purchase
• Insurance coverage now overtakes premium as the top factor in term insurance purchase
• Citizens from the West Zone increasingly invest with intent – child’s education, marriage, and old age security top priorities

PUNE: Axis Max Life Insurance Limited. (“Axis Max Life” / “Company”), formerly known as Max Life Insurance Company Limited, has unveiled the West Zone findings of the seventh edition of its flagship survey – India Protection Quotient (IPQ), conducted in partnership with KANTAR, the world’s leading marketing data and analytics company. The findings from the West Zone reveal a steady improvement in protection sentiment, led by rising awareness of term insurance and growing intent to use life insurance as a tool for long-term financial planning.

Axis Max Life is launching the India Protection Quotient 7.0 under the unified narrative of ‘Bharosa Talks’ that will spotlight India’s evolving financial and protection mindset. Through this platform, Axis Max Life aims to amplify real voices across demographics – urban, rural, salaried, gig workers, and retirees, offering authentic insights into how India views protection, planning, and long-term security. As financial anxieties shift over time and aspirations evolve, Bharosa Talks will serve as a critical pulse for industry, regulators, and policymakers to understand emerging consumer priorities.

As per IPQ 7.0, the Protection Quotient in the West Zone has maintained a score one point higher than the national urban average, reaffirming the region’s consistent progress in life insurance awareness and confidence. While security and ownership levels remain stable, a significant uptick in term plan awareness and adoption has contributed to the zone’s strong standing.

Sumit Madan, Chief Distribution Officer, Axis Max Life, said, “The West Zone’s sustained progress in the Protection Quotient reflects a clear shift in consumer mindset. IPQ 7.0 points to a maturing market, especially among the salaried class and metro residents in cities like Mumbai, where people are moving beyond basic insurance ownership toward more purpose-driven financial planning. More consumers are now prioritizing adequate term coverage over low premiums, with long-term family goals at the center of their decisions. This signals a deeper understanding of life insurance as a key pillar of financial security. While this progress is encouraging, affordability remains a barrier, particularly for the self-employed. This presents a clear opportunity for the Indian life insurance industry to innovate with more flexible, inclusive solutions and to strengthen advisory outreach. Doing so will not only expand access but also play a vital role in building a more resilient and financially protected India.”

The IPQ 7.0 study continues to shine a light on evolving consumer behaviour across India, with the West Zone’s performance offering both insights and inspiration for other regions seeking to strengthen financial protection and awareness.

West Zone Outpaces National Average in Protection Preparedness: IPQ 7.0

The West Zone has outperformed the national urban average in the latest India Protection Quotient (IPQ) 7.0, underscoring a growing shift toward protection-led financial planning. With a Protection Quotient (PQ) one point higher than the national urban average, the region demonstrates rising awareness and an evolving approach to life insurance, despite lingering financial barriers.

Protection Quotient and Knowledge Index on the Rise

The findings highlight a notable uptick in the Knowledge Index among West Zone respondents, indicating improved understanding of insurance products and financial planning. While life insurance ownership and perceived financial security have remained stable, the overall Protection Quotient growth signals increasing intent toward safeguarding future financial well-being.

Term Insurance: Coverage Now Trumps Cost

For the first time, West Zone citizens have shown a clear preference for coverage over premium when buying term insurance. This represents a fundamental behavioural shift, aligning with a broader national trend that favours adequate protection over affordability alone. The zone has seen a marked increase in both awareness and ownership of term plans, cementing its position as a growing hub of insurance-conscious consumers.

Investment Motivated by Family-Centric Goals

The report also reveals a more values-driven approach to investing, with over 40% of West Zone respondents citing goal-based investing as their strategy. Key financial priorities include children’s education, marriage, retirement planning, and purchasing assets such as homes and cars — all pointing toward a more holistic and purpose-led financial mindset.

Persistent Financial Constraints Remain a Challenge

Despite this progress, financial constraints continue to hinder broader adoption. One in three respondents in the West Zone cite premium affordability as a major barrier, particularly among self-employed individuals and first-time insurance buyers. This underlines the need for flexible, accessible insurance products and greater financial literacy efforts to close the protection gap.

Salaried Individuals Drive Regional Growth

The PQ surge in the West is largely driven by salaried professionals, who have shown significant improvement in their Knowledge Index. In contrast, self-employed individuals have exhibited stagnant performance across key indicators, suggesting the need for targeted advisory services and more inclusive product outreach.

Mumbai Leads Among Metros

Among major metropolitan areas, Mumbai has emerged as the top performer in Protection Quotient within the West Zone, and shares the top rank in the Knowledge Index with Bengaluru. The city reflects high engagement with insurance products and a strong sense of financial preparedness, positioning it as a model for urban financial resilience.

The post Rise of Life Insurance Awareness in the West Zone appeared first on NRI News.

AHMEDABAD: Bajaj Allianz Life Insurance, one of India’s leading private life insurance providers, expresses its deepest condolences to the families affected by the tragic aircraft crash in the Meghani Nagar area of Ahmedabad on June 12, 2025. In response to this unfortunate incident, the Company has activated special measures to assist families of its policyholders affected by the crash.

Understanding the immense challenges faced by the affected lives assured’s families during this difficult time, Bajaj Allianz Life Insurance has established a dedicated special claims settlement desk to prioritize the processing of death and disability claims for its customers impacted due to this tragedy. With utmost urgency, an expeditious process has been established to swiftly settle these policy claims.

To simplify the process, Bajaj Allianz Life Insurance has listed a minimal documentation process that nominees, legal heirs, or policyholders need to submit to process their claims. In case the Death Certificate is not immediately available, a certificate issued by the municipal authority or hospital will also be accepted to initiate the claim process, along with the nominee KYC and bank mandate. Claims can be notified, and details can be submitted through any of the following convenient modes:

• Call the company’s toll-free number 1800-209-7272
• Visit one of the nearest branches among the 596 branches across the country
• Email at: claims@bajajallianz.co.in

Bajaj Allianz Life Insurance remains committed to supporting its policyholders through challenging circumstances and will continue to provide prompt assistance to those affected by the Ahmedabad tragedy.

The post Bajaj Allianz Life Insurance Offers Swift Claims Support for Policyholders Affected by Ahmedabad Tragedy appeared first on NRI News.

KOCHI: Ahead of World Blood Cancer Day, DKMS Foundation India, a leading non-profit organization dedicated to the fight against blood cancer and other blood disorders, honoured lifesavers from Kerala who have given patients a second chance at life. These eight warriors selflessly donated blood stem cells to save the lives of patients battling blood cancer and blood disorders. These generous donors shared their deeply personal journeys, recounting how the act of donation not only saved strangers’ lives but also profoundly transformed their own. Moved by their own experiences, they urged more individuals to come forward, register as potential stem cell donors, and become the hope someone urgently needs to survive.

To mark World Blood Cancer Day, observed on May 28, DKMS Foundation India organized a special event to celebrate the incredible spirit of stem cell donation. At the event, eight donors, Sai (doctor from Calicut), Midhun (IT professional from Calicut), Kishor (IT professional from Palakkad), Abdul (IT professional from Malappuram), Sanjay (IT professional from Trivandrum), Hameem (civil engineer from Kollam), Amina (general physician from Kozhikode), and Rashid (graduate from Kerala) were felicitated for their selfless act of donating blood stem cells. Their actions have not only given patients a new lease on life but have also made them influential ambassadors of awareness and hope.

In India, blood cancer patients often face overwhelming odds when it comes to accessing life-saving stem cell transplants. With only 1 in a million people likely to find a fully matched donor, searching for a suitable match becomes an urgent and often heartbreaking struggle against time. Despite the proven, life-changing potential of stem cell transplantation, the severe shortage of registered donors remains a major barrier to timely treatment. Each year, over 70,000 lives are lost to blood cancer in the country, a disease that accounts for 8% of all new cancer diagnoses.

Patrick Paul, Chairman, DKMS  India, said: “Behind every blood cancer diagnosis is a family holding on to hope, and that hope often hinges on finding a matching stem cell donor. In a country of over a billion people, the fact that only 0.5 million are registered as potential donors is a gap we cannot afford. Kerala has shown encouraging intent with over 21,964 registrations, but we need many more to step forward. A single act of kindness can mean the difference between life and loss for someone, somewhere.”

Dr. Nitin Agarwal, MD, Transfusion Medicine, HoD, Donor Request Management, DKMS Foundation India, said: “A blood stem cell transplant from a matching HLA donor is often the most promising chance of survival for patients with blood cancer or severe blood disorders. However, only about 30% of patients can find a suitable match within their families. The remaining 70% depend on unrelated donors, but with just 0.09% of India’s population registered, the odds are heartbreakingly low. Increasing awareness and donor registrations is not just important, it’s lifesaving.”

He added: “Misconceptions that stem cell donation is painful or harmful continue to discourage many from registering. The procedure is safe, straightforward, and has no lasting impact on the donor’s health. By spreading awareness and addressing these fears, we can motivate more people to become lifesaving donors.”

Dr. Amina A.P. Shahala, a 25-year-old general physician and donor from Kozhikode, said: “As a doctor, I have always believed in healing, but donating my blood stem cells gave me a unique chance to save a life beyond the hospital walls. The process was safe, well-guided, and deeply fulfilling. Knowing that someone, somewhere, has a second chance at life because of my simple act is truly heartening.”

Sharing his experience, Rashid, a 28-year-old graduate from Kerala, said: “Knowing that my stem cell donation gave someone a second chance at life is an indescribable feeling. It’s rare to get an opportunity to make such a profound impact, and I am grateful to DKMS for guiding me through the process with such care. I encourage everyone to register because becoming a donor means becoming someone’s hope.”

Dr. Chepsy C. Philip, Clinical Hematology & Bone Marrow Transplant Physician at Believers Church Medical College Hospital, Thiruvalla, said: “Blood cancers like lymphoma, myeloma, and leukemia continue to claim lives in India, yet stem cell transplants offer real hope—with success rates of 60–80% when performed on time. However, while over 100,000 patients need transplants each year, fewer than 3,000 receive one. Every day, I see patients desperately waiting for a match. Each new donor isn’t just a number—it’s a lifeline. We need many more, and we need them now.”

Since its inception in 2019, DKMS Foundation India has registered over 200,000 potential stem cell donors and facilitated more than 160 transplants, playing a crucial role in the fight against blood cancer. The foundation remains committed to saving lives by expanding its donor registry both in India and globally.

To register as a potential stem cell donor, one must be a healthy adult between 18 and 55 years of age. Registration requires filling up a simple consent form. A swab of the inside of the cheeks is taken to collect the tissue cells, which are then sent to a lab to be analysed for HLA (Human Leukocyte Antigen). The potential donor is then listed anonymously on the international search platform for matching stem cell donors. Eligible individuals can register as blood stem cell donors by ordering a home swab kit at https://www.dkms-india.org/register-now and join the movement to save lives.

The post DKMS Foundation India Celebrates and Honors Stem Cell Donors Who Transform Lives of Blood Cancer Patients appeared first on NRI News.

You’re talking to someone and suddenly they fall silent, their face sags, or their speech is slurred. It’s frightening—but it’s what you do after that can save their life.

A stroke occurs when blood flow to the brain is cut off or disrupted. Without oxygen, brain cells start to die within a matter of minutes. Immediate action can make the difference between a full recovery and disability, or even death. Stroke is one of the major causes of death and disability worldwide. However, many people don’t know what to do during those important initial moments. Here are five lifesaving steps you should take if someone close to you is having a stroke.

Act FAST to Recognize the Signs – The simplest way to identify a stroke is to remember FAST:

• F – Face: Is one side of the face drooping when smiling?
• A – Arms: Is one arm sagging when raised?
• S – Speech: Is one’s speech slurring or abnormal?
• T – Time: Time to call emergency services right away.

Other symptoms can be sudden vision loss, confusion, dizziness, or a bad headache.

Call Emergency Services Immediately – The moment someone notices these symptoms, it is very important to call for an ambulance. Don’t take the person yourself—paramedics can start treatment en route and notify the hospital to have stroke care ready. Early treatment is essential, particularly if clot-dissolving medication is administered within a small window (usually 3–4.5 hours after the attack).

Write Down the Time of Symptom Onset – Doctors will need to know exactly when symptoms started. This determines which treatments are possible. If you don’t know, note the last time the person was seen “normal.” Save the time on your phone or write it down. Every minute counts.

Keep the Person Safe and Still –

•  Place them on their side if they’re vomiting or unconscious.
• Unbutton and loosen tight clothing.
• Do not give food, water, or medication—swallowing could be compromised, leading to choking.

Don’t assume – Don’t assume it’s low blood sugar or a seizure. And don’t ever administer NSAIDs unless told to by a doctor—it can make the situation worse with a bleeding stroke. Even if the symptoms immediately go away (like in the case of a mini-stroke or TIA), call emergency services. It may be an early warning of a more imminent stroke to come.

Strokes can happen at a moment’s notice, but your reaction does not have to be. Recognizing the symptoms and moving quickly can save a life or spare the person from lifelong disability. Learn the FAST signs and share them with others.

The post 5 Critical Actions to Save a Life During a Stroke Emergency appeared first on NRI News.

MUMBAI: Reliance Nippon Life Insurance Company Ltd. (RNLIC), one of India’s leading life insurance companies, today announced its audited financial results for the financial year ended March 31, 2025. The company delivered a steady performance across key metrics while continuing to strengthen its customer focus and operational resilience.

For FY2024- 25, RNLIC reported a Profit Before Tax (PBT) of ₹247 crore, reflecting a strong growth of 25% over the previous year (₹198 crore in FY2023- 24). The company’s Assets Under Management (AUM) stood at ₹38,725 crore, marking a 9% year-on-year growth. New Business Premium (NBP) grew to ₹1,245 crore, and Total Premium rose to ₹5,711 crore, reflecting steady business momentum.

The company continued to maintain a strong Solvency Ratio of 235%, well above the regulatory requirement, reflecting a robust balance sheet and prudent capital management.

Customer-centricity remained a core pillar, with a Claim Settlement Ratio of 98.9%, as on March 31, 2025, and ₹3,523 crore paid in benefits to ~5.4 lakh customers during the year, an increase of 8% over the previous year. The company’s 13th-month persistency for FY2024- 25 by premium* stood at a healthy 80.8%, reflecting strong customer trust and continued engagement. The number of active advisors grew by 13%, increasing its active advisor base to nearly 69,000, further strengthening the company’s reach and advisory capability.

In a reaffirmation of its long-term commitment, RNLIC declared bonuses to its participating policyholders and distributed bonuses totalling ₹351 crore during the FY24- 25, rewarding 5.2 lakh customers for their continued confidence in the company. This marks the 24^th year of consistent bonus declarations, supporting RNLIC’s promise of long-term value creation and financial security for its customers.

The company’s Embedded Value rose to ₹7,397 crore, up from ₹6,885 crore in the last fiscal, supported by consistent business performance and improved operational efficiencies.

Key Financial Highlights (₹ in crore):

Employee Focus: Certified as a Great Place to Work in 2025 (Source: GPTW), for the sixth consecutive year, highlighting commitment to employee well-being. Also recognized as Top 50 Large Workplaces: Building a Culture of Innovation for All.

Product Innovation: Launched 6 new innovative and thoughtful products complying with IRDAI Regulations across various segments that cater to the varied needs of our customers.

Commenting on the performance, Ashish Vohra, Executive Director & CEO, Reliance Nippon Life Insurance Company, said: “We are pleased to report a year marked by strong performance and improved profitability, driven by disciplined execution, customer-first thinking, and robust fundamentals. Our continued focus on strengthening distribution, enhancing customer experience, and maintaining financial prudence has helped us navigate a dynamic environment. The combined strength of IIHL and Nippon Life Insurance, backed by their shared commitment to long-term growth and excellence, will help us unlock greater outcomes for all stakeholders, drive strategic expansion, and continue building a legacy of trust for the future. We remain committed to building a future-ready, customer-centric life insurance company with a clear vision to scale and lead with trust, innovation, and performance.”

*As per the IRDAI public disclosure methodology for regular/limited pay premium

The post Reliance Nippon Life Insurance Company Ltd. Reports Strong Performance for FY2024-25 appeared first on NRI News.

PUNE: Bajaj Allianz Life Insurance, one of India’s leading private life insurers, has announced a record bonus of ₹1,833 crore for the financial year 2024–25 (FY25), its highest ever to date. This marks a significant 32% increase over the ₹1,383 crore bonus declared in FY24. The bonus will benefit over 11.71 lakh policyholders who have invested in the Company’s participating (with-profit) products. With this declaration, Bajaj Allianz Life continues its strong legacy of delivering value to customers, having consistently announced annual bonuses for 24 consecutive years.

Policyholders with traditional participating policies that are in force as of March 31, 2025, are eligible to receive this bonus, which is declared from the surplus generated under the participating fund. Bajaj Allianz Life offers a diverse range of participating products, including, Bajaj Allianz Life Ace (A Non linked, Participating, Individual Life Insurance Savings Plan), Bajaj Allianz Life Ace Advantage (A Non Linked, Participating, Life Insurance Savings Plan) , and Bajaj Allianz Life Elite Assure (A Non-Linked Participating Individual Life Insurance Savings Plan) designed to provide customers with enhanced flexibility to meet their varied life goals. Policyholders of these plans stand to benefit from the bonus declared, amongst others.

Additionally, the Company has announced a special reversionary bonus of 5% for policyholders of higher equity allocation products, Bajaj Allianz Life ACE – Wealth Option and Bajaj Allianz Life Flexi Income Goal – Enhanced Benefit (A Non-Linked, Participating, Guaranteed Income Life Insurance Plan), amounting to ₹206 crores.

Speaking on this announcement, Tarun Chugh, MD & CEO, Bajaj Allianz Life Insurance, said, “We are happy to announce our highest-ever annual participating (PAR) bonus of ₹1,833 crore this year. It highlights the strength of our prudent investment strategies and strong financial foundation that help us in delivering gains for our customers. As a customer-first life insurer, we are committed to performance-driven solutions that genuinely deliver by helping people achieve their life goals with confidence.”

Bonuses declared in each financial year are distributed at the time of policy maturity or exit. In addition, cash bonuses will be disbursed on policy anniversary, or as outlined in the respective policy terms.

The post Bajaj Allianz Life Announces Record Bonus of ₹1,833 Crore for Participating Policyholders appeared first on NRI News.